Dimitri Livitz

Nord Bio Inc

$175,215

Attributed

$350,429

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $295.8K · FY2024–25

$500K$375K$250K$125K$0

'24

'25

Funding mix

By agency

NIH$350,429 · 1

By mechanism

R43$350,429 · 1

Top collaborators

Ignaty Leshchiner2 shared

Most similar at Nord Bio Inc

Same institution · by research overlap

Ignaty Leshchiner$175,215

Others in their field

Other Rising Stars on “Detection”

Alaina J Harkness · Current Innovation, Nfp$13,724,091
Kari A Stephens · University Of Washington$9,270,394
Nancy Glenn · Boise State University$8,000,000
Sarah Biber · University Of Washington$7,911,975
Shaunna Shen · Duke University$7,747,008
Rangarajan Sampath · Siemens Healthcare Diagnostics Inc.$5,422,657

Research focus

DetectionDna MethylationAlgorithmsCost EffectivenessDiagnosisBiologicalBiological MarkersBiopsyAssay DevelopmentCostDetection MethodDetection SensitivityCancer CellCancer DetectionCancer DiagnosisCancer GenomicsCancer RecurrenceCause Of DeathBloodCellsBlood CellsConsumptionComputing MethodologiesEarly Diagnosis

Grant awards (2)

Non-invasive cancer detection and residual disease monitoring by cell-free nucleic acid from saliva$54,672

R43 · FY2025 · CA

Non-invasive cancer detection and residual disease monitoring by cell-free nucleic acid from saliva$295,757

R43 · FY2024 · CA